Concepedia

Publication | Closed Access

Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab

36

Citations

35

References

2016

Year

Abstract

Calprotectin showed the strongest correlation with measures of disease activity and may be better than S100A12 when evaluating disease activity in RA patients. More extensive studies are needed to further compare the predictive value of the S100 proteins relative to radiographic progression.

References

YearCitations

1988

19.8K

1990

7.7K

1995

6.1K

1990

3.1K

1965

1.7K

2012

1.3K

1999

1.2K

1996

1K

1989

564

2004

277

Page 1